DBVT

Dbv Technologies S A

• Seeking Alpha·20h ago

  Artisan International Small-Mid Fund Q2 2026 Portfolio Review

• TipRanks·07/30 21:45

  DBV Technologies announces sale of $50M of ADSs through ATM program

• Seeking Alpha·07/26 12:23

  DBV Technologies: Regulatory Noise, Commercial Misperception, And A Deep Valuation Gap

• Seeking Alpha·07/23 20:46

  DBV Technologies: Viaskin's FDA Path Still Leaves Room For More Upside

• TipRanks·07/22 12:30

  Fourteen new option listings and one option delisting on July 22nd

• TipRanks·07/17 21:05

  DBV Technologies announces $150M at-the-market offering

• TipRanks·07/17 14:20

  Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and Kalaris Therapeutics (KLRS)

• TipRanks·07/17 12:30

  Analysts Offer Insights on Healthcare Companies: Insmed (INSM), AbCellera Biologics (ABCL) and DBV Technologies SA – American (DBVT)

• TipRanks·07/17 12:25

  Cantor Fitzgerald Keeps Their Buy Rating on DBV Technologies SA – American (DBVT)

• TipRanks·07/17 11:10

  Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT), Intuitive Surgical (ISRG) and Staar Surgical (STAA)

• TipRanks·07/16 20:10

  DBV Technologies reports Q2 EPS (12c), consensus (9c)

• Seeking Alpha·07/16 20:04

  DBV Technologies GAAP EPS of -$0.12 beats by $0.06

• Benzinga·07/16 20:03

  DBV Technologies Q2 EPS $(0.12) Misses $(0.10) Estimate, Sales $700.000K Miss $1.391M Estimate

• TipRanks·07/01 10:55

  Guggenheim Sticks to Their Buy Rating for DBV Technologies SA – American (DBVT)

• TipRanks·06/30 17:35

  DBV Technologies: Buy Rating Reaffirmed with Unchanged $46 Price Target as VIASKIN Peanut BLA Timeline and Regulatory Path De‑Risk